These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 26239566)
41. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas]. Wei QY; Wu YQ; Fan SQ Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069 [TBL] [Abstract][Full Text] [Related]
42. The β5/focal adhesion kinase/glycogen synthase kinase 3β integrin pathway in high-grade osteosarcoma: a protein expression profile predictive of response to neoadjuvant chemotherapy. Le Guellec S; Moyal EC; Filleron T; Delisle MB; Chevreau C; Rubie H; Castex MP; de Gauzy JS; Bonnevialle P; Gomez-Brouchet A Hum Pathol; 2013 Oct; 44(10):2149-58. PubMed ID: 23845472 [TBL] [Abstract][Full Text] [Related]
43. A reassessment of bone scintigraphy and commonly tested pretreatment biochemical parameters in newly diagnosed osteosarcoma. Stokkel MP; Linthorst MF; Borm JJ; Taminiau AH; Pauwels EK J Cancer Res Clin Oncol; 2002 Jul; 128(7):393-9. PubMed ID: 12136254 [TBL] [Abstract][Full Text] [Related]
44. Knockdown of IRX2 inhibits osteosarcoma cell proliferation and invasion by the AKT/MMP9 signaling pathway. Liu T; Zhou W; Zhang F; Shi G; Teng H; Xiao J; Wang Y Mol Med Rep; 2014 Jul; 10(1):169-74. PubMed ID: 24806332 [TBL] [Abstract][Full Text] [Related]
45. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy. Unsal D; Akyurek N; Uner A; Erpolat OP; Han U; Akmansu M; Mentes BB; Dursun A Am J Clin Oncol; 2008 Feb; 31(1):55-63. PubMed ID: 18376229 [TBL] [Abstract][Full Text] [Related]
46. Selaginella tamariscina (Beauv.) possesses antimetastatic effects on human osteosarcoma cells by decreasing MMP-2 and MMP-9 secretions via p38 and Akt signaling pathways. Yang JS; Lin CW; Hsieh YS; Cheng HL; Lue KH; Yang SF; Lu KH Food Chem Toxicol; 2013 Sep; 59():801-7. PubMed ID: 23811101 [TBL] [Abstract][Full Text] [Related]
47. Meta-analysis of alkaline phosphatase and prognosis for osteosarcoma. Hao H; Chen L; Huang D; Ge J; Qiu Y; Hao L Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 27349943 [TBL] [Abstract][Full Text] [Related]
48. Prognostic role of pathologic fracture in osteosarcoma: Evidence based on 1,677 subjects. Yang M J Cancer Res Ther; 2015; 11(2):264-7. PubMed ID: 26148581 [TBL] [Abstract][Full Text] [Related]
49. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer. Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771 [TBL] [Abstract][Full Text] [Related]
50. ROCK1 as a potential therapeutic target in osteosarcoma. Liu X; Choy E; Hornicek FJ; Yang S; Yang C; Harmon D; Mankin H; Duan Z J Orthop Res; 2011 Aug; 29(8):1259-66. PubMed ID: 21387396 [TBL] [Abstract][Full Text] [Related]
51. Expression of matrix metalloproteinase (MMP)-1, MMP-2, MMP-9, cathepsin B, and urokinase plasminogen activator in non-skull base chordoma. Naka T; Boltze C; Kuester D; Schulz TO; Samii A; Herold C; Ostertag H; Roessner A Am J Clin Pathol; 2004 Dec; 122(6):926-30. PubMed ID: 15539385 [TBL] [Abstract][Full Text] [Related]
52. The Clinical Utility of Matrix Metalloproteinase 9 in Evaluating Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis. Yang X; Lv S; Liu Y; Li D; Shi R; Tang Z; Fan J; Xu Z Mol Neurobiol; 2015 Aug; 52(1):38-44. PubMed ID: 25108671 [TBL] [Abstract][Full Text] [Related]
53. Expression of Leptin and Sirtuin-1 is associated with poor prognosis in patients with osteosarcoma. Feng H; Guo P; Wang J; Xu J; Xie C; Gao F Pathol Res Pract; 2016 Apr; 212(4):319-24. PubMed ID: 26936024 [TBL] [Abstract][Full Text] [Related]
54. Prognostic value of MMP-9 in ovarian cancer: a meta-analysis. Li LN; Zhou X; Gu Y; Yan J Asian Pac J Cancer Prev; 2013; 14(7):4107-13. PubMed ID: 23991961 [TBL] [Abstract][Full Text] [Related]
55. Matrix metalloproteinase-9 activity is associated with poor prognosis in T3-T4 node-negative colorectal cancer. Cho YB; Lee WY; Song SY; Shin HJ; Yun SH; Chun HK Hum Pathol; 2007 Nov; 38(11):1603-10. PubMed ID: 17669467 [TBL] [Abstract][Full Text] [Related]
56. Impact of vascular endothelial growth factor expression on overall survival in patients with osteosarcoma: a meta-analysis. Zhuang Y; Wei M Tumour Biol; 2014 Mar; 35(3):1745-9. PubMed ID: 24515658 [TBL] [Abstract][Full Text] [Related]
57. Letter regarding Wen X.Y. et al. entitled "Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis". Guo HB; Xiao T Tumour Biol; 2014 May; 35(5):5053. PubMed ID: 24449508 [No Abstract] [Full Text] [Related]
58. Prognostic significance of matrix metalloproteinase-2 in gynecological cancer: a systemic review of the literature and meta-analysis. Peng H; Liu L; Zhao X J BUON; 2013; 18(1):202-10. PubMed ID: 23613407 [TBL] [Abstract][Full Text] [Related]
59. Prognostic significance of matrix metalloproteinase 7 immunohistochemical expression in colorectal cancer: a meta-analysis. Chen H; Hu Y; Xiang W; Cai Y; Wang Z; Xiao Q; Liu Y; Li Q; Ding K Int J Clin Exp Med; 2015; 8(3):3281-90. PubMed ID: 26064217 [TBL] [Abstract][Full Text] [Related]
60. Letter regarding "Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis" by Guo et al. Wang P; Sun L; Yu L; Wang H Tumour Biol; 2014 Jul; 35(7):6175. PubMed ID: 24504679 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]